Pure Global
NCT06364475

Could a Time-restricted Diet Compete With a Calorie-restricted 6-meal Diet?

Comparing the Effects of Time-restricted Eating and Three Meals-three Snacks Diet on Body Composition and on Biochemical Parameters
Bezmialem Vakif University·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Overweight and Obesity
Drug/Device/Intervention
16:8 Time-Restricted Intermittent Fasting Group
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Bezmialem Vakif University
Location
İ̇stanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2021
End date
Sep 01, 2022
Enrollment
137 participants
Primary outcome

Weight measured in kilogram

Summary

The prevalence of obesity and obesity-related diseases are on the rise worldwide. The widely
 accepted approach in dietary treatment of obesity is the calorie-restricted three meals-three
 snacks a day diet; however, alternative approaches are needed. This study was conceived with
 a view to comparing time-restricted eating, a method which can be easily conveyed and applied
 in overcoming obesity, to a six meals a day diet. 174 participants aged between 18-65 with a
 BMI25 kg/m2 were included. Diet lists with similar calorie, macro counts suitable for their
 respective group were prepared. Anthropometric measurements, blood pressure, blood tests were
 analyzed before the study and at the end of the 8-week.

ICD-10 classifications
ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06364475
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06364475 through Pure Global AI's free database. This phase not specified trial is sponsored by Bezmialem Vakif University and is currently Completed. The study focuses on Overweight and Obesity. Target enrollment is 137 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.